Multiplex Detection Immunoassays - Global Strategic Business Report

The global market for Multiplex Detection Immunoassays was estimated at US$2.8 Billion in 2023 and is projected to reach US$3.5 Billion by 2030, growing at a CAGR of 3.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

What Are Multiplex Detection Immunoassays and How Do They Work?

Multiplex detection immunoassays are specialized diagnostic tools that allow the simultaneous measurement of multiple antigens or antibodies in a single sample using immunological detection methods. These assays utilize antibodies to specifically bind to target molecules, enabling the detection and quantification of multiple analytes simultaneously, making them invaluable in both clinical diagnostics and research. Multiplex detection immunoassays are widely used in immunology, infectious diseases, and oncology to monitor immune responses, detect biomarkers, and diagnose diseases early. Their ability to provide high-throughput, detailed results from minimal samples offers considerable advantages over traditional single-analyte assays, streamlining workflows and enhancing diagnostic accuracy.

How Are Technological Innovations Transforming Multiplex Detection Immunoassays?

Technological advancements in assay design, detection methods, and microfluidics are rapidly enhancing the performance of multiplex detection immunoassays. Innovations in fluorescent and chemiluminescent detection systems have significantly improved the sensitivity and specificity of these assays, enabling the detection of lower levels of biomarkers. Microfluidics and lab-on-a-chip technologies have also allowed for more compact, efficient multiplex assays, reducing sample and reagent volumes while increasing throughput. Furthermore, the integration of digital technologies, such as AI-driven data analysis and automated platforms, is improving the speed and accuracy of interpreting assay results. These advancements are making multiplex detection immunoassays more versatile, expanding their applications in personalized medicine, vaccine development, and point-of-care diagnostics.

How Is the Demand for Precision Diagnostics Boosting the Use of Multiplex Detection Immunoassays?

The growing emphasis on precision diagnostics, which involves tailoring medical treatment to individual patients based on their unique molecular profiles, is driving the adoption of multiplex detection immunoassays. These assays enable clinicians to analyze multiple disease markers in a single test, providing a more comprehensive understanding of a patient's health status. In infectious disease diagnostics, for example, multiplex assays allow for the simultaneous detection of multiple pathogens, improving diagnostic accuracy and treatment speed. In oncology, these assays are being used to monitor immune responses to cancer therapies and detect tumor markers. The demand for more efficient and detailed diagnostics in personalized medicine is fueling the growth of multiplex detection immunoassays across various healthcare applications.

What Are the Key Growth Drivers in the Multiplex Detection Immunoassays Market?

The growth in the multiplex detection immunoassays market is driven by several factors, including technological advancements, the increasing demand for precision diagnostics, and the growing focus on early disease detection. Innovations in detection technologies and assay design are making these immunoassays more sensitive and scalable, allowing for broader adoption in clinical diagnostics and research. The rising prevalence of chronic and infectious diseases, such as cancer and COVID-19, is pushing the need for more comprehensive diagnostic tools, driving the use of multiplex detection immunoassays. Additionally, the expansion of personalized medicine and the growing importance of biomarker discovery are contributing to the demand for these assays, as they allow for more detailed analysis of disease states and treatment responses.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Disease Testing Application segment, which is expected to reach US$1.5 Billion by 2030 with a CAGR of a 4.0%. The Food Contamination Testing Application segment is also set to grow at 3.5% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, which was valued at $734.1 Million in 2023, and China, forecasted to grow at an impressive 3.3% CAGR to reach $563.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Multiplex Detection Immunoassays Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Multiplex Detection Immunoassays Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Multiplex Detection Immunoassays Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as BD Biosciences, Bio-Rad Laboratories, Inc., Danaher Corporation, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 14 Featured):

BD Biosciences
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
Luminex Corporation
Microsynth AG
MilliporeSigma
Qiagen NV
Quansys Biosciences
Thermo Fisher Scientific, Inc.
Unisensor

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Global Economic Update
Multiplex Detection Immunoassays - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Demand for High-Throughput Diagnostic Testing Propels Growth in Multiplex Detection Immunoassays
Increasing Prevalence of Infectious Diseases Expands Addressable Market for Multiplex Detection Immunoassays
Growing Focus on Personalized Medicine Strengthens Business Case for Multiplex Detection Immunoassays in Biomarker Discovery
Technological Advancements in Immunoassay Platforms Propel Innovation in Multiplex Detection Systems
Surge in Oncology Research Drives Adoption of Multiplex Detection Immunoassays in Cancer Diagnostics
Increasing Use of Multiplex Detection Immunoassays in Vaccine Development Expands Opportunities in Pandemic Response
Growth in Point-of-Care Diagnostics Drives Demand for Rapid and Portable Multiplex Immunoassay Kits
Rising Importance of Immunotherapy Expands Market for Multiplex Detection Immunoassays in Immunology
Increasing Focus on Reducing Healthcare Costs Fuels Demand for Cost-Effective Multiplex Testing Solutions
Expansion of Companion Diagnostics in Targeted Therapies Drives Market for Multiplex Detection Immunoassays
Technological Advancements in Microfluidics and Lab-on-a-Chip Platforms Propel

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Multiplex Detection Immunoassays Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
Table 2: World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 3: World Historic Review for Multiplex Detection Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 4: World 16-Year Perspective for Multiplex Detection Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
Table 5: World Recent Past, Current & Future Analysis for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 6: World Historic Review for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 7: World 16-Year Perspective for Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 8: World Recent Past, Current & Future Analysis for Food Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 9: World Historic Review for Food Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 10: World 16-Year Perspective for Food Contamination Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 11: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 12: World Historic Review for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 13: World 16-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 14: World Recent Past, Current & Future Analysis for Veterinary Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 15: World Historic Review for Veterinary Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 16: World 16-Year Perspective for Veterinary Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 17: World Recent Past, Current & Future Analysis for Protein-Based Multiplex Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 18: World Historic Review for Protein-Based Multiplex Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 19: World 16-Year Perspective for Protein-Based Multiplex Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 20: World Recent Past, Current & Future Analysis for Nucleic Acid Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 21: World Historic Review for Nucleic Acid Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 22: World 16-Year Perspective for Nucleic Acid Based Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 23: World Recent Past, Current & Future Analysis for Biosensor Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 24: World Historic Review for Biosensor Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 25: World 16-Year Perspective for Biosensor Based Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES

Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 26: USA Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 27: USA Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 28: USA 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 29: USA Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 30: USA Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 31: USA 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

CANADA

Table 32: Canada Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 33: Canada Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 34: Canada 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 35: Canada Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 36: Canada Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 37: Canada 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

JAPAN

Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Table 38: Japan Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 39: Japan Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 40: Japan 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 41: Japan Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 42: Japan Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 43: Japan 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

CHINA

Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Table 44: China Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 45: China Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 46: China 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 47: China Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 48: China Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 49: China 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

EUROPE

Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 50: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 51: Europe Historic Review for Multiplex Detection Immunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 52: Europe 16-Year Perspective for Multiplex Detection Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
Table 53: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 54: Europe Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 55: Europe 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 56: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 57: Europe Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 58: Europe 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

FRANCE

Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Table 59: France Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 60: France Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 61: France 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 62: France Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 63: France Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 64: France 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

GERMANY

Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Table 65: Germany Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 66: Germany Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 67: Germany 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 68: Germany Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 69: Germany Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 70: Germany 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

ITALY

Table 71: Italy Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 72: Italy Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 73: Italy 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 74: Italy Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 75: Italy Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 76: Italy 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

UNITED KINGDOM

Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Table 77: UK Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 78: UK Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 79: UK 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 80: UK Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 81: UK Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 82: UK 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

REST OF EUROPE

Table 83: Rest of Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 84: Rest of Europe Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 85: Rest of Europe 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 86: Rest of Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 87: Rest of Europe Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 88: Rest of Europe 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

ASIA-PACIFIC

Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 90: Asia-Pacific Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 91: Asia-Pacific 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 93: Asia-Pacific Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 94: Asia-Pacific 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

REST OF WORLD

Table 95: Rest of World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 96: Rest of World Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 97: Rest of World 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2024 & 2030
Table 98: Rest of World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 99: Rest of World Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 100: Rest of World 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2024 & 2030

IV. COMPETITION

Companies Mentioned

BD Biosciences
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
Luminex Corporation
Microsynth AG
MilliporeSigma
Qiagen NV
Quansys Biosciences
Thermo Fisher Scientific, Inc.
Unisensor

Table Information

Report Attribute	Details
No. of Pages	182
Published	November 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 2.8 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.5 Billion
Compound Annual Growth Rate	3.5%
Regions Covered	Global
No. of Companies Mentioned	11

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4836EUR$4,950USD£4,038GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9189EUR$9,405USD£7,671GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14509EUR$14,850USD£12,113GBP

What Are Multiplex Detection Immunoassays and How Do They Work?

How Are Technological Innovations Transforming Multiplex Detection Immunoassays?

How Is the Demand for Precision Diagnostics Boosting the Use of Multiplex Detection Immunoassays?

What Are the Key Growth Drivers in the Multiplex Detection Immunoassays Market?

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 14 Featured):

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Multiplex Detection Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Multiplex Detection Immunoassays Market by Technique, Assay Type, Application, End-User - Global Forecast 2025-2030

Multiplex Detection Immunoassay Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027

Lateral Flow Immunoassay (LFIA)-based Rapid Test Global Market Report 2024